Summary
Updated Aug 30, 2026
Brian Koopman is Principal Financial Officer of UTAH MEDICAL PRODUCTS INC (UTMD). 4 SEC Form 4 filings on record going back to 2024, most recently on 29 May 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Brian Koopman has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Brian Koopman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Susan E. Burwig - $33.58M of MEDP open-market activity in the last 12 months
- Michael B. Petras Jr. - $33.51M of SHC open-market activity in the last 12 months
- Reuven Yeganeh - $33.32M of PHGE open-market activity in the last 12 months
- Adage Capital Management, L.P. - $33.20M of PRAX open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $33.00M of REPL open-market activity in the last 12 months
- Casdin Capital, LLC - $32.57M of WGS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Brian Koopman?
Brian Koopman is a corporate insider, tracked as Principal Financial Officer of UTAH MEDICAL PRODUCTS INC (UTMD). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Brian Koopman last file a Form 4?
The most recent primary Form 4 on record is dated 29 May 2026, one of 4 filings going back to 2024.
Where can I see all of Brian Koopman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Brian Koopman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
